Gyre Therapeutics, Inc. financial data

Symbol
GYRE on Nasdaq
Industry
Pharmaceutical Preparations
Location
12770 High Bluff Drive, Suite 150, San Diego, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
CATALYST BIOSCIENCES, INC. (to 10/27/2023), TARGACEPT INC (to 8/19/2015)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 314 % -27.3%
Debt-to-equity 101 % -46.2%
Return On Equity -302 % +46.3%
Return On Assets -85.5 % -26.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 93.4M shares +146%
Common Stock, Shares, Outstanding 85.5M shares +125%
Entity Public Float 11.1M USD -80.1%
Common Stock, Value, Issued 85K USD +130%
Weighted Average Number of Shares Outstanding, Basic 85.5M shares +34.5%
Weighted Average Number of Shares Outstanding, Diluted 104M shares +32.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 25.2M USD -14%
Research and Development Expense 3.36M USD -5.97%
Selling and Marketing Expense 14.4M USD -19.9%
General and Administrative Expense 18M USD +50.5%
Costs and Expenses 22M USD -9.82%
Operating Income (Loss) -67.5M USD -322%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -70.6M USD -354%
Income Tax Expense (Benefit) 8.42M USD -8.84%
Net Income (Loss) Attributable to Parent -79M USD -219%
Earnings Per Share, Basic -1.35 USD/shares -26.2%
Earnings Per Share, Diluted -1.42 USD/shares -29.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 16.1M USD +133%
Cash, Cash Equivalents, and Short-term Investments 33.5M USD +54.4%
Accounts Receivable, after Allowance for Credit Loss, Current 564K USD -43.9%
Inventory, Net 5.64M USD
Other Assets, Current 1.72M USD
Assets, Current 53.5M USD +602%
Deferred Income Tax Assets, Net 5.08M USD
Property, Plant and Equipment, Net 23.7M USD
Operating Lease, Right-of-Use Asset 2.1M USD
Other Assets, Noncurrent 1.28M USD +661%
Assets 121M USD +876%
Accounts Payable, Current 271K USD +5320%
Liabilities, Current 15.6M USD +458%
Operating Lease, Liability, Noncurrent 1.3M USD
Other Liabilities, Noncurrent 47K USD
Liabilities 27.6M USD +273%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.01M USD
Retained Earnings (Accumulated Deficit) -74.5M USD +82%
Stockholders' Equity Attributable to Parent 60.4M USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 93.3M USD +20.5%
Liabilities and Equity 121M USD +876%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.88M USD -72.3%
Net Cash Provided by (Used in) Financing Activities 658K USD
Net Cash Provided by (Used in) Investing Activities -7.22M USD +5.6%
Common Stock, Shares Authorized 400M shares +300%
Common Stock, Shares, Issued 85.5M shares +125%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.72M USD -225%
Deferred Tax Assets, Valuation Allowance 63.8M USD +13.8%
Deferred Tax Assets, Gross 68.7M USD +1545%
Operating Lease, Liability 1.96M USD
Payments to Acquire Property, Plant, and Equipment 231K USD -86.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3.25M USD
Lessee, Operating Lease, Liability, to be Paid 2.09M USD
Property, Plant and Equipment, Gross 28.5M USD
Operating Lease, Liability, Current 659K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 598K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 735K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 132K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 281K USD
Deferred Tax Assets, Operating Loss Carryforwards 40.7M USD -0.25%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 1.83M USD
Operating Lease, Payments 139K USD +9.45%
Additional Paid in Capital 134M USD -65.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 8.5K USD -82.3%
Depreciation, Depletion and Amortization 415K USD +50.4%
Deferred Tax Assets, Net of Valuation Allowance 4.7M USD +15%
Share-based Payment Arrangement, Expense 7.01M USD -45.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%